International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic

September 11, 2021

The COVID-19 pandemic brought changes to the way people work, socialise and spend leisure time.This study documented the prevalence of clinical cases of insomnia, anxiety, and depression and selected risk factors (COVID-19, confinement, financial burden, social isolation) during the first wave of the pandemic from May to August 2020.Over a third of respondents reported clinical insomnia symptoms, and almost a fifth met criteria for a probable insomnia disorder.Research shows that when you treat insomnia, you often not only see improvements in sleep, but reductions in anxiety and depressive symptoms, and improvement in mental health and wellbeing.This study provides further evidence of the impact of sleep on mental health and how we can begin addressing the mental health crisis through evidenced-based insomnia interventions.’

The source of this news is from University of Oxford